Answers are grounded in this paper and cite their sources.
Background Microwave ablation (MWA) and liver resection (LR) are both established treatment options for hepatocellular carcinoma (HCC), but comparative evidence on survival outcomes and safety for gallbladder-adjacent HCC remains lacking.Materials and methods Between January 2006 and December 2024, 1,242 patients with primary HCC from five tertiary hospitals who underwent MWA or LR as first-line therapy were identified. Primary endpoints were overall survival (OS) and progression-free survival (PFS); secondary endpoints were complications, operative time, hospital stay, and costs. Propensity score overlap weighting balanced baseline characteristics, with propensity score matching as a sensitivity analysis. Survival was assessed using Kaplan-Meier analysis, log-rank test, and multivariable Cox regression with subgroup analyses.Results A total of 254 patients were included, with 66 in the MWA group and 188 in the LR group. After overlap weighting, no significant difference in OS was observed (p = 0.315), whereas LR showed significantly better PFS (p = 0.048). Multivariable analysis revealed that treatment modality was not an independent predictor of OS (p = 0.310) or PFS (p = 0.096). Subgroup analysis showed no significant treatment interaction for OS (p = 0.193) or PFS (p = 0.986). MWA demonstrated comparable complications, with shorter operative time, shorter hospital stay, and lower cost than LR (all p < 0.001).Conclusion In conclusion, for gallbladder-adjacent HCC, MWA achieved OS and a safety profile comparable to LR, while offering shorter operative time, shorter hospital stay, and lower cost, suggesting MWA may be an effective and less invasive alternative in selected patients.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: